Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

S&P Biotech SPDR (XBI)

S&P Biotech SPDR (XBI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family State Street Global Advisors
  • Assets Under Management 5,931,064,000
  • Market Capitalization, $K 5,931,064
  • Shares Outstanding, K 52,100
  • 60-Month Beta 1.57
  • Price/Earnings ttm 17.87
  • Annual Dividend & Yield 0.02 (0.02%)
  • Most Recent Dividend 0.017 on 06/22/20
  • Management Fee 0.35%
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
107.69 +1.57%
on 07/31/20
121.06 -9.65%
on 07/21/20
-5.54 (-4.82%)
since 07/10/20
3-Month
97.15 +12.59%
on 06/12/20
121.06 -9.65%
on 07/21/20
+5.06 (+4.85%)
since 05/11/20
52-Week
62.94 +73.78%
on 03/18/20
121.06 -9.65%
on 07/21/20
+25.35 (+30.17%)
since 08/09/19

Most Recent Stories

More News
How Will Biotech ETFs React to Q2 Earnings Release?

Let's take a look at some ETFs with exposure to major players in the U.S. biotech industry, post their Q2 earnings releases amid the coronavirus crisis.

BIIB : 289.94 (-3.44%)
ALXN : 101.24 (-0.63%)
GILD : 68.10 (-0.60%)
AMGN : 234.65 (-1.48%)
IBB : 131.88 (-2.22%)
XBI : 109.38 (-3.98%)
BBH : 159.08 (-1.55%)
Should You Invest in the Invesco Dynamic Biotechnology Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 59.03 (-2.02%)
REGN : 598.86 (-1.54%)
AMGN : 234.65 (-1.48%)
SRPT : 158.03 (-0.61%)
IBB : 131.88 (-2.22%)
XBI : 109.38 (-3.98%)
Red Hot ETF Areas Amid the Coronavirus Crisis

Let's check out some ETF areas that will remain solid investment picks even as the coronavirus cases show a sharp spike.

IBB : 131.88 (-2.22%)
XBI : 109.38 (-3.98%)
PNQI : 189.52 (-1.66%)
FBT : 162.26 (-1.39%)
ARKW : 96.10 (-2.21%)
FDN : 179.83 (-1.74%)
ESGU : 75.40 (-0.85%)
ESGV : 60.84 (-0.83%)
OGIG : 40.10 (-1.50%)
USSG : 30.13 (-0.63%)
Moderna Turns Red Hot: Biotech ETFs to Bet On

Moderna skyrocketed 245% since it announced its COVID-19 vaccine candidate mRNA-1273 on Feb 10. The solid run is likely to continue as most of the analysts are optimistic on the stock.

MRNA : 68.97 (-4.22%)
IBB : 131.88 (-2.22%)
CNCR : 25.89 (-1.62%)
XBI : 109.38 (-3.98%)
BBH : 159.08 (-1.55%)
BTEC : 44.11 (-2.96%)
IDNA : 37.47 (-2.37%)
GERM : 30.07 (-6.03%)
Late-Stage Coronavirus Vaccine Trials Begin: Biotech ETFs to Gain

Two major vaccine developers' entrance into the final stage trials is expected to boost investor optimism.

JNJ : 146.97 (-0.72%)
AZN : 55.18 (-0.36%)
PFE : 37.79 (-1.56%)
MRNA : 68.97 (-4.22%)
NVAX : 149.48 (-16.26%)
IBB : 131.88 (-2.22%)
XBI : 109.38 (-3.98%)
BBH : 159.08 (-1.55%)
FBT : 162.26 (-1.39%)
ARKG : 56.25 (-3.60%)
Stocks Rise Again Amid Vaccine, Stimulus News

Stocks Rise Again Amid Vaccine, Stimulus News

LOVE : 30.84 (-4.84%)
TPB : 29.80 (-0.67%)
SUM : 17.50 (+0.75%)
XBI : 109.38 (-3.98%)
IBB : 131.88 (-2.22%)
VNQ : 81.33 (-1.44%)
PFE : 37.79 (-1.56%)
MSFT : 203.38 (-2.34%)
TSLA : 1,374.39 (-3.11%)
Biotech ETFs to Gain on Coronavirus Vaccine Progress

The race to find a coronavirus vaccine is heating up as the latest positive data from progress in trials are being published.

AZN : 55.18 (-0.36%)
MRNA : 68.97 (-4.22%)
IBB : 131.88 (-2.22%)
XBI : 109.38 (-3.98%)
BBH : 159.08 (-1.55%)
FBT : 162.26 (-1.39%)
ARKG : 56.25 (-3.60%)
4 ETF Areas to Keep Soaring as Coronavirus Cases Rise

In the current scenario, the rising work-from-home and online shopping trend, increasing digital payments, growing video streaming and soaring video game sales are slowly becoming the "new normal."

IBB : 131.88 (-2.22%)
HACK : 47.83 (-1.36%)
XBI : 109.38 (-3.98%)
CIBR : 34.64 (-0.83%)
IBUY : 88.13 (-2.60%)
BOTZ : 26.36 (+0.23%)
SKYY : 74.89 (-1.24%)
CLIX : 85.73 (-2.40%)
ROBT : 37.69 (-0.60%)
CLOU : 21.26 (-2.34%)
Moderna Inches Closer to Coronavirus Vaccine: ETFs to Shine

Moderna plans to begin the Phase 3 study of mRNA-1273 this month.

PFE : 37.79 (-1.56%)
MRNA : 68.97 (-4.22%)
IBB : 131.88 (-2.22%)
CNCR : 25.89 (-1.62%)
XBI : 109.38 (-3.98%)
BBH : 159.08 (-1.55%)
FBT : 162.26 (-1.39%)
BTEC : 44.11 (-2.96%)
IDNA : 37.47 (-2.37%)
GERM : 30.07 (-6.03%)
How to Tap Red-Hot Moderna Stock With ETFs

Moderna shares have surged more than 280% so far this year on the positive development of coronavirus vaccine.

MRNA : 68.97 (-4.22%)
IBB : 131.88 (-2.22%)
CNCR : 25.89 (-1.62%)
XBI : 109.38 (-3.98%)
BBH : 159.08 (-1.55%)
BTEC : 44.11 (-2.96%)
IDNA : 37.47 (-2.37%)
GERM : 30.07 (-6.03%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade XBI with:

Fund Summary

The SPDR SP Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Biotechnology Select Industry Index.

See More

Key Turning Points

2nd Resistance Point 115.59
1st Resistance Point 112.48
Last Price 109.38
1st Support Level 107.66
2nd Support Level 105.95

See More

52-Week High 121.06
Last Price 109.38
Fibonacci 61.8% 98.86
Fibonacci 50% 92.00
Fibonacci 38.2% 85.14
52-Week Low 62.94

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar